Main > A1. CORP. INDEX. I-Im > Impax/P C2
Impax/P C2's subsections
2002. 09.23.2002. (AntiHistaminics)
2002. 09.23.2002. (CNS Brand Drugs)
2002. 09.23.2002. (Executive)
2002. 09.23.2002. (Niche Generics)
2002. 09.23.2002. (Pneumology)
2012. 03.26.2012. Tolmar Inc.
2012. 04.12.2012. PHN>Gabapentin
2012. 06.26.2012. Tolmar Inc.
2012. 06.29.2012. Resignation
2012. 11.16.2012. Patent Challenge
2012. 12.13.2012. CFO
2013. 01.04.2013. AnAlgesics
2013. 02.08.2013. Adderall XR
2013. 05.17. Migraine
2013. 06.25. CEO To Retire
2013. 07.03. Uro.>OAB
2013. 07.15. Fenofibric Acid DR Cap
2013. 10.25. Risedronate Na DR Tab
2013. 11.21. Diclofenac Na-Gel 3%
2013. 12.03. Patent Challenge
2014. 01.07. PHN>Bupivacaine Patch
2014. 04.21. Pres. & CEO
2014. 10.09. Acq. Tower Holdings
2015. 01.08. Neuro.>PD
2015. 01.26. Neuro.>Epilepsy
2015. 06.16. Migraine Pediatrics
2015. 09.17. myasthenia gravis.
2015. 10.21. guanfacine ER Tab.
2015. 11.24. Uro.>PBH
2015. 11.25. Neuro.>PD
2016. 01.15. Worm Infections
2016. 02.02. CV.>HyperCholest.
2016. 06.21. Teva Pharma
2016. 09.22. Psychiatry>ADHD
2016. 12.22. Pain.>Morphine.SO4
2017. 03.30. Zolmitriptan Patent
2017. 04.26. Generic Vytorin
2017. 10.17. Co. & Amneal Merger
2017. 12.08. CV.>Generic Coreg CRŽ
Global Pharmaceuticals Div. C2
Patents
Web-Site
Impax/P C2's products
This section has no products